Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study.

Journal of immunology research - 1 Jan 2020

Milanesi Elena, Dobre Maria, Bucuroiu Alina Ioana, Herlea Vlad, Manuc Teodora Ecaterina, Salvi Alessandro, De Petro Giuseppina, Manuc Mircea, Becheanu Gabriel

Abstract excerpt

microRNAs (miRNAs) have been proposed as promising molecular biomarkers for diagnosis, prognosis, and responsive therapeutic targets in different types of cancer, including colorectal cancer (CRC). In this study, we evaluated the expression levels of 84 cancer-associated miRNAs in a cohort of 39 human samples comprising 13 peritumoral and 26 tumoral tissues from surgical specimens of CRC patients. KRAS mutations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colonic Neoplasms

Share to Colorectal Neoplasms

Share to Gene Expression Regulation, Neoplastic

Share to MicroRNAs

Share to Proto-Oncogene Proteins p21(ras)

Share to Transcriptome

Source

Open in PubMed Open full text

Identifiers

PMID: 32676506
DOI: 10.1155/2020/4927120
PMCID: PMC7330647

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study.PMID 32676506Read ↗

MicroRNA profiling differentiates colorectal cancer according to KRAS status.Semantic proximity Read ↗

From strings to signals: Unraveling the impact of miRNAs on diagnosis, and progression of colorectal cancer.Semantic proximity Read ↗

MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment.Semantic proximity Read ↗

KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics.Semantic proximity Read ↗

Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer.Semantic proximity Read ↗

The current understanding on the impact of KRAS on colorectal cancer.Semantic proximity Read ↗

MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.Semantic proximity Read ↗

Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients.Semantic proximity Read ↗

Differences in gene mutation profiles of colon cancer patients with or without a KRAS mutationSemantic proximity Read ↗

Identification of A Four-Microrna Panel in Serum As Promising Biomarker for Colorectal Carcinoma DetectionSemantic proximity Read ↗

Identification of key pathways and genes in mutant KRAS colorectal cancer by integrated bioinformatics analysis.Semantic proximity Read ↗

Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.